Talk:Angela Hartley Brodie

A list of information about her works to be included in article..
Hello all,

Me and User: Worm That Turned have tried our best with this article though we have a very limited knowledge of medical research. I am hoping to enlist assistance from very helpful editors at the Medical Project!


 * 1973 published initial studies on Aromatase Inhibitors
 * 1982 tested inhibitors - England collaboration
 * Cancer treatment - Aromatase inhibitors
 * Developed Formestane first aromatase inhibitor to be used on breast cancer patients 1994 was first marketed
 * Now developing steroidal compounds to stop reoccurring cancers.
 * Working on Prostate cancer.
 * History of her early works with husband
 * 200 papers in journals.
 * "She has served on many NIH and NCI study sections as well as being a reviewer and . She is also a member of the Advisory Board for the Komen Foundation."
 * 2014 report about her current work.
 * She was an ad-hoc member of the integration panel for the U.S. Army department of Defense Army breast cancer research program

Thanks, ツStacey (talk) 17:53, 25 January 2016 (UTC)

Timeline
A source says

''Angela Brodie continued research at the Worcester Foundation for eighteen years, developing aromatase inhibitors and showing their clinical efficacy in model systems. Harry Brodie took a different path, leaving laboratory research in 1978 and becoming an administrator at the NIH.

''It was eagerness to initiate clinical trials of aromatase inhibitors that brought Angela Brodie to the University of Maryland in 1979.

Of course working backwards from 1979 gives 1961 as her arrival time. However I am pretty sure another source has her arriving in 1963.

All the best: Rich Farmbrough, 19:25, 21 February 2016 (UTC).


 * Indeed, according to History of Aromatase: Saga of an Important Biological Mediator and Therapeutic Target she arrived in 1962. All the best: Rich Farmbrough, 19:38, 21 February 2016 (UTC).

Context
We should place the aromatase inhibitors work in the context of the following:

History of.... etc.

All the best: Rich Farmbrough, 19:52, 21 February 2016 (UTC).


 * Sadly the references in that document appear to be broken. All the best: Rich Farmbrough, 19:54, 21 February 2016 (UTC).


 * http://press.endocrine.org/doi/abs/10.1210/endo-92-3-866 Possibly the first publication on aromatase inhibitors?
 * http://press.endocrine.org/doi/abs/10.1210/endo-100-6-1684 Results on reproductive supression and neoplasms (in rats).